In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 ...

Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose ...

They've all dosed multiple cohorts of patients and we actually have some very exciting preclinical assets like our antibody drug conjugates ... to Japan and Taiwan, regions where 33% to 40% ...

The binding affinity of an antibody to its antigen is largely ... a CDR loop whereas the other two are in the neighboring framework region (Fig. 2). In the mutant C10, the net charge of the ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein ...

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

WASHINGTON (AP) — House Republicans narrowly approved their budget framework Thursday, a political turnaround after Speaker Mike Johnson worked into the night to satisfy GOP holdouts who had ...